Expression of Ret/PTC1, -2, 3, -Δ3 and -4 in German papillary thyroid carcinoma

British Journal of Cancer

Volumn 77, Issue 6, 1998, Pages 903-906

  Mayr, B ^a   Potter E ^a   Goretzki, P ^b   Ruschoff J ^c   Dietmaier, W ^c   Hoang Vu, C ^d   Dralle, H ^d   Brabant, G ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Ret proto oncogene; Ret PTC oncogene; Thyroid papillary carcinoma

Indexed keywords

ARTICLE; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; ONCOGENE; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA;

EID: 0031912469     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.149     Document Type: Article

References (29)

1. Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti MAM and Italy (1993) Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit R1 alpha of cyclic AMP-dependent protein kinase A. Molec Cell Biol 13 358-366
2. Bongarzone I, Fugazzola L, Vigneri P, Mariani L, Mondellini P, Pacini F, Basolo F, Pinchera A, Pilotti S and Pierotti MA (1996) Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab 81: 2006-2009
3. Fabien N, Paulin C, Santoro M, Berger N, Grieco M, Galvain D, Barbier Y, Dubois PM and Fusco A (1992) Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation. Br J Cancer 66: 1094-1098
4. Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG and Demidchik EP (1995) Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 55: 5617-5620
5. Fugazzola, L, Pierotti MA, Vigano E, Pacini F, Vorontsova TV and Bongarzone I (1996) Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELEI genes, in a post-Chernobyl papillary thyroid cancer. Oncogene 13: 1093-1097
6. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A and Vecchio G (1990) PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60: 557-563
7. Grieco M, Cerrato A, Santoro M, Fusco A, Melillo RM and Vecchio, G (1994) Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. Oncogene 9: 2531-2535
8. Ishizaka Y, Ushijima T, Sugimura T and Nagao, M (1990) cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. Biochem Biophys Res Commun 168: 402-408
9. Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N and Akiyama M (1993) In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res 53: 2940-2943
10. Jhiang SM and Mazzaferri, EL (1994) The ret/PTC oncogene in papillary thyroid carcinoma. J Lab Clin Med 123: 331-337
11. Jhiang SM, Sagartz JE, Tong Q, Parker Thornburg J, Capen CC, Cho JY, Xing S and Ledent C (1996) Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137: 375-378
12. Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW and Fox GM (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85: 1113-1124
13. Klugbauer S, Lengfelder H, Demidchik EP and Rabes HM (1995) High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 11: 2459-2467
14. Klugbauer S, Lengfelder E, Demidchik EP and Rabes HM (1996) A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident. Oncogene 13: 1099-1102
15. Mayr B, Brabant G, Goretzki P, Ruschoff J, Dietmaier W and Dralle. H (1997) ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? J Clin Endocrinol Metab 82: 1306-1307
16. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryan AM, Carver Moore K and Rosenthal A (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature 382: 76-79
17. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A and Ponder BAJ (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458-460
18. Nikiforov Y and Fagin, A (1997) Risk factors for thyroid cancer. Trend Endocrinol Metab 8: 20-25
19. Pichel JG, Shen L, Sheng HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H and Westphal H (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382: 73-76
20. Sanchez MP, Silos-Santiago I, Frinsén J, He B, Lira SA and Barbacid, M (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382: 70-73
21. Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N, Peix JL, Paulin C, Fabien N, Vecchio G, Jenkins RB and Fusco A (1992) Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Endocrinol Invest 89: 1517-1522
22. Santoro M, Sabino N, Ishizaka Y, Ushijima T, Carlomagno F, Cerrato A, Grieco M, Battaglia C, Martelli ML, Paulin C et al (1993) Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. Br J Cancer 68: 460-464
23. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A (1994) Molecular characterization of RET/PTC3: a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9: 509-516
24. Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G and Fusco A (1996) Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 12: 1821-1826
25. Schuchardt A, D'Agati V, Larsson Blomberg L, Costantini F and Pachnis V (1995) RET-deficient mice: an animal model for Hirschsprung's disease and renal agenesis. J Intern Med 238: 327-332
26. Sugg L, Zheng L, Rosen I, Freeman J, Ezzat S and Asa. S (1996) ret/PTC-1, -2, and -3 oncogene rearrangement in human thyroid carcinomas: implications for metastatic potential? J Clin Endocrinol Metab 81: 3360-3365.
27. Williams GH, Rooney S, Thomas GA, Cummins G and Williams ED (1996) RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Br J Cancer 74: 585-589
28. Xing S, Smanik PA, Oglesbee MJ, Trosko JE, Mazzaferri EL and Jhiang. SM (1996) Characterization of ret oncogenic activation in MEN2 inherited cancer syndromes. Endocrinology 137: 1512-1519
29. Zou M, Shi Y and Farid NR (1994) Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer 73: 176-180